Apogenix
Meinolf Thiemann is currently the VP Preclinical Development at Apogenix GmbH, where Meinolf manages research and development activities and supports clinical development. Prior to this role, Meinolf held positions at Santhera Pharmaceuticals as the Head of Assay Development, focusing on setting up biochemical protein assays for drug discovery. Meinolf Thiemann holds a Dr. rer. nat. in Biochemistry and Cell Biology from Heidelberg University and a Master's degree in Biology from Bielefeld University.